RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Feb 19, 2013 - 1:22:36 AM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
UIC researchers to study how young adults use e-cigarettes, snus

Feb 7, 2013 - 5:00:00 AM
Co-investigators are Don Hedeker, Kathi Diviak, Jason Leigh, Steve Jones, Robert Kenyon and Alicia Matthews of UIC, and Thomas Piasecki of the University of Missouri.

 
[RxPG] Researchers at the University of Illinois at Chicago's Institute for Health Research and Policy have received a $2.3 million federal grant to study how young adults use hookahs, snus, electronic cigarettes, and other new tobacco products.

What's intriguing and potentially challenging about the introduction of these new products is that they are perceived by many people as being safer products and alternatives to traditional, combustible tobacco, says Robin Mermelstein, director of the UIC institute and principal investigator of the National Cancer Institute-funded study.

Young adults are a vulnerable population, said Mermelstein, a professor of psychology at UIC.

Our study is going to look at what some of their motivations are for using these products; how they use them; where they use them, she said. Does it increase their overall tobacco dependence? Or, perhaps, does it help them reduce their tobacco dependence?

Many young adults and older adults think such products are not tobacco and are not harmful, Mermelstein said. They may even believe that the government has endorsed their safety.

Electronic cigarettes, also known as e-cigs, are battery-operated devices that produce a vaporized or aerosolized nicotine -- known to be addictive -- which is inhaled. The smokeless devices can be used in non-smoking environments and are not regulated in most states. They do not carry FDA health warning labels.

The researchers will follow approximately 230 young adults, ages 18 to 30, who regularly use non-cigarette forms of tobacco. The participants will carry electronic diaries to record how and when they use tobacco each day.

The researchers will try to assess if the subjects are using the alternative tobacco products in conjunction with cigarettes, as a bridge or a delaying tactic to quitting smoking, as a style statement, or if they are using the products simultaneously with alcohol or drugs.

Young adults are a big market for tobacco companies, as they are often willing to try new products and experiment in a variety of settings, Mermelstein said. She and her coworkers also hope to develop new ways to convey factual information about alternative tobacco products to young adults.

We're interested in seeing if there are effective and persuasive visual messages that we can convey through smartphone applications, to let people know what it is about these products that might make them harmful or helpful, Mermelstein said.

Co-investigators are Don Hedeker, Kathi Diviak, Jason Leigh, Steve Jones, Robert Kenyon and Alicia Matthews of UIC, and Thomas Piasecki of the University of Missouri.

The project is supported by the National Cancer Institute, one of the National Institutes of Health, under award number P01CA098262.



Related Latest Research News
Drug activates virus against cancer
Bone loss associated with increased production of ROS
Sound preconditioning prevents ototoxic drug-induced hearing loss in mice
Crystal methamphetamine use by street youth increases risk of injecting drugs
Johns Hopkins-led study shows increased life expectancy among family caregivers
Moderate to severe psoriasis linked to chronic kidney disease, say experts
Licensing deal marks coming of age for University of Washington, University of Alabama-Birmingham
Simple blood or urine test to identify blinding disease
Physician job satisfaction driven by quality of patient care
Book explores undiscovered economics of everyday life

Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)